DarioHealth Announces Upcoming Q3 2026 Financial Results and Conference Call Timing
DarioHealth Corp., publicly traded under the NASDAQ symbol DRIO, is set to disclose its financial performance for the third quarter of 2026 on Thursday, November 12. Investors and stakeholders are eagerly awaiting insights from the leading AI-powered healthcare technology firm that is reshaping chronic condition management. The release will be followed by a conference call scheduled for 8:30 AM Eastern Time, where key executives will share results and future outlook.
The conference call will feature Erez Raphael, CEO; Lara Dodo, COO; and Chen Franco-Yehuda, CFO, giving an overview of the company’s performance, major developments, and strategic initiatives. Participants are encouraged to dial in approximately 10 minutes before the call to ensure connectivity.
Call-in Numbers:
For those who prefer immediate access, a 'Call me™' link will be made available 15 minutes prior to the start of the event.
Stakeholders and the media can also join the conference via a live webcast, providing an alternative platform to engage with the company's updates. Following the live session, a recording will be accessible approximately three hours later, extending through November 26.
DarioHealth is recognized for its advanced approaches to healthcare technology that empower health plans, systems, and employers to optimize health outcomes while simultaneously reducing costs. The company's integrated platform leverages AI-driven insights as well as personalized member engagement, combining connected devices with clinical support tailored to individual health needs.
With a foundation of over 13 billion proprietary healthcare data points gathered over the past decade, the Dario health platform personalizes treatment by utilizing biometric, clinical, and behavioral data, ensuring timely interventions for individuals managing conditions such as diabetes and hypertension.
This quarterly earnings announcement is not just a routine update; it marks a significant moment for Dario as it continues to solidify its leadership within the evolving healthcare landscape, particularly in contexts where AI is paving new pathways to care and management. Stakeholders await confirmation on not just the financial metrics but insights into the company's strategic direction amid a competitive healthcare market.
As a reminder, all statements related to future performance are forward-looking statements, and actual results may vary significantly due to various factors. This includes regulatory approvals and market dynamics that can heavily influence operational outcomes. Interested parties are encouraged to remain informed by reviewing updates and filings made available through the Securities and Exchange Commission.
Contact Information
For further inquiries regarding DarioHealth’s financial outlook, you can reach the company directly via their investor relations contact, Michael Lipari, SVP Corporate Development.
As DarioHealth approaches this pivotal release, the anticipation surrounding their report underscores the ongoing transformation in the healthcare technology sector and the critical role that advanced AI solutions play in managing chronic diseases effectively for diverse patient populations.
Conference Call Details
The conference call will feature Erez Raphael, CEO; Lara Dodo, COO; and Chen Franco-Yehuda, CFO, giving an overview of the company’s performance, major developments, and strategic initiatives. Participants are encouraged to dial in approximately 10 minutes before the call to ensure connectivity.
Call-in Numbers:
- - Domestic: 1-800-717-1738
- - International: 1-646-307-1865
For those who prefer immediate access, a 'Call me™' link will be made available 15 minutes prior to the start of the event.
Webcast Availability
Stakeholders and the media can also join the conference via a live webcast, providing an alternative platform to engage with the company's updates. Following the live session, a recording will be accessible approximately three hours later, extending through November 26.
DarioHealth is recognized for its advanced approaches to healthcare technology that empower health plans, systems, and employers to optimize health outcomes while simultaneously reducing costs. The company's integrated platform leverages AI-driven insights as well as personalized member engagement, combining connected devices with clinical support tailored to individual health needs.
With a foundation of over 13 billion proprietary healthcare data points gathered over the past decade, the Dario health platform personalizes treatment by utilizing biometric, clinical, and behavioral data, ensuring timely interventions for individuals managing conditions such as diabetes and hypertension.
This quarterly earnings announcement is not just a routine update; it marks a significant moment for Dario as it continues to solidify its leadership within the evolving healthcare landscape, particularly in contexts where AI is paving new pathways to care and management. Stakeholders await confirmation on not just the financial metrics but insights into the company's strategic direction amid a competitive healthcare market.
Cautionary Note
As a reminder, all statements related to future performance are forward-looking statements, and actual results may vary significantly due to various factors. This includes regulatory approvals and market dynamics that can heavily influence operational outcomes. Interested parties are encouraged to remain informed by reviewing updates and filings made available through the Securities and Exchange Commission.
Contact Information
For further inquiries regarding DarioHealth’s financial outlook, you can reach the company directly via their investor relations contact, Michael Lipari, SVP Corporate Development.
As DarioHealth approaches this pivotal release, the anticipation surrounding their report underscores the ongoing transformation in the healthcare technology sector and the critical role that advanced AI solutions play in managing chronic diseases effectively for diverse patient populations.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.